ImageneBio, Inc. IMA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 800.00K | 800.00K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00 | 0.00 | 800.00K | 800.00K | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00 | 0.00 | 800.00K | 800.00K | -- |
| SG&A Expenses | 27.50M | 24.09M | 20.73M | 17.88M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.96M | 54.54M | 49.25M | 46.89M | -- |
| Operating Income | -58.96M | -54.54M | -48.45M | -46.09M | -- |
| Income Before Tax | -52.81M | -50.23M | -45.70M | -43.31M | -- |
| Income Tax Expenses | -324.00K | -340.00K | -350.00K | -61.00K | -- |
| Earnings from Continuing Operations | -52.48 | -49.89 | -45.35 | -43.25 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.48M | -49.89M | -45.35M | -43.25M | -- |
| EBIT | -58.96M | -54.54M | -48.45M | -46.09M | -- |
| EBITDA | -58.37M | -54.04M | -48.05M | -46.07M | -- |
| EPS Basic | -4.49 | -8.32 | -11.17 | -10.56 | -- |
| Normalized Basic EPS | -2.78 | -4.35 | -5.34 | -4.95 | -- |
| EPS Diluted | -4.49 | -8.32 | -11.17 | -10.56 | -- |
| Normalized Diluted EPS | -2.78 | -4.35 | -5.34 | -4.95 | -- |
| Average Basic Shares Outstanding | 49.74M | 35.98M | 27.17M | 478.10M | -- |
| Average Diluted Shares Outstanding | 49.74M | 35.98M | 27.17M | 478.10M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |